Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?

Pharmacogenomics. 2014 Apr;15(6):719-22. doi: 10.2217/pgs.14.18.


“In clinical practice, it is common for warfarin to be initiated at a fixed dose for the first several doses.”

Keywords: CYP2C9; VKORC1; clinical utility; pharmacogenetics; pharmacogenomics; randomized controlled clinical trial; warfarin.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Clinical Trials as Topic
  • Humans
  • International Normalized Ratio / methods
  • Pharmacogenetics / methods
  • Randomized Controlled Trials as Topic
  • Warfarin / administration & dosage*


  • Warfarin